Rogers T, et al. - Presuming that invasive electrophysiology studies (EPS) could reduce permanent pacemaker (PPM) implantation rates following transcatheter aortic valve implantation (TAVI) by identifying patients who do not require long-term pacing, researchers adopted a new strategy in which patients with equivocal indications for pacing underwent EPS to determine the need for PPM implantation. They identified EPS to be a safe strategy for TAVI patients with new-onset conduction disturbance to identify those who require PPM implantation and those in whom PPM can be avoided.